Third booster with half dose of Pfizer vaccine as effective as full dose - study

14 Sept 02:52 Key points summarised by AI

Thailand's Siriraj Institute of Clinical Research recommends a half-dose Pfizer booster shot after two AstraZeneca doses, citing its comparable effectiveness to a full dose.
A study found that a half-dose Pfizer booster generates antibody levels nearly as high as a full dose, particularly following initial Sinovac or AstraZeneca vaccinations.
Specifically, a half-dose Pfizer booster achieved 1,962 BAU/ml, closely approaching the 2,377 BAU/ml from a full dose, demonstrating robust antibody production.
For individuals with two Sinovac jabs, a half-dose Pfizer booster yielded superior antibody levels against the Delta variant (499) compared to a full dose (411).
The research confirmed that participants experienced only mild to moderate undesirable side effects across the tested booster regimens.

Uthenthawai students and alumni declare truce with Pathumwan rivals

Yesterday 20:34 Key points summarised by AI

Uthenthawai students and alumni have pledged to cease violent clashes with Pathumwan Institute rivals, coinciding with their campus's reopening after a 90-day closure.
The Minister of Higher Education is mediating the long-running conflict, while the campus closure has significantly disrupted in-person classes and laboratory work for over 1,000 students.
Uthenthawai resists relocation from its current site, citing a historical land grant from King Rama VI, despite Chulalongkorn University's plans to reclaim the land for an educational hub.
Concerns are mounting over the legality of the campus closure, its detrimental impact on uninvolved students, and the potential commercial development of the land, which critics argue contradicts the late King Rama VI's intentions.